Cost and efficacy of dissection devices in extended and parenchyma preserving liver resection: a prospective randomised trial

Completed

• Conditions: Primary or secondary hepatic malignacy; Cancer; Malignant neoplasm of liver and intrahepatic bile ducts

• Registration Number: ISRCTN52294555
• Lead Sponsor: niversity of Saarland (Germany)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-08-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

All patients undergoing liver resection for primary or secondary hepatic malignancy of any age and gender.

Exclusion Criteria

1. Cirrhosis or cholestasis (serum bilirubin greater than 25 mg/dl)
2. Prior chemotherapy (within 6 months) and multiple liver tumours

Study & Design

• Study Type: Interventional
• Study Design: Not specified